Is the world better prepared for the next pandemic? It is a key question five years on from the COVID-19 pandemic. Lessons have been learnt but many of the same weaknesses and vulnerabilities that allowed COVID-19 to gain a foothold exist today. “In an environment of fiscal tightening, governments may be inclined to adopt a short-term perspective in which global health slips further down their political priorities. But global health investments deliver an incredible return on investment [...] Threats from infectious disease have not been vanquished”, states a new Lancet Editorial. Read more ➡️ https://hubs.li/Q032ctHR0 Alt: A person in protective gear carries out measures against bird flu at Karlsruhe Zoo, Germany. Image credit: Photo by Uli Deck/picture alliance via Getty Images
What is often overlooked is that diseases do not "strive" alone. They need inadequate control measures, disinformation, unprepared health systems, defunding of organizations which play essential roles in public health, lack of access to health services for huge population groups... We need to think about crisis preparedness constantly.
Loud and clear messages from COVID-19 fallen on deaf ears. Sad! When politics takes on science.
The COVID-19 pandemic highlighted the critical need for long-term investment in global health systems. While progress has been made, it’s concerning that many vulnerabilities remain. Governments must prioritize global health to strengthen preparedness and ensure resilience against future pandemics. Investing in health today is investing in a safer tomorrow.
The WHO by May MUST pass a #PandemicTreaty to ensure global health threats are swiftly and equitably dealt with. Past pandemics have demonstrated how wealthy nations effectively monopolize the global vaccine supply. This has led to avoidable deaths, not least during the COVID-19 pandemic. This can be stopped from happening again through a Pandemic Treaty that can: increase medicines manufacturing capacity globally, include all countries in preparedness efforts and share intellectual property rights, technology, and know-how during emergencies.
Professional SUPPLIER of Guanidine salts,fire retardant and phase transfer catalyst.
2moAn essential question! While we've made strides in diagnostics and response tools—such as leveraging guanidine thiocyanate for rapid and reliable RNA extraction during COVID-19—many systemic vulnerabilities remain. As the Lancet Editorial highlights, sustained investment in global health offers unparalleled returns, both economically and in safeguarding resilience. The challenge is ensuring these lessons translate into lasting action, even amid fiscal pressures. Global health security must remain a top priority—how can we collectively push this agenda forward?